Glenmark Pharmaceuticals Limited — Updates, 21-08-2026: Press Release
21-08-2026 | 08:52 am
21-08-2026 | 08:52 am
Glenmark's US unit launched Calcium Gluconate Injection USP, strengthening its injectables business. This product enters a US market with estimated annual sales of ~$69.9 million (~₹580 Cr), enhancing its hospital portfolio.
No comments yet. Be the first to comment!
